Ange Postecoglou will face the media today ahead of Tottenham's Premier League game with Ipswich Town on Sunday. The is holding his pre-match press conference at Hotspur Way ahead of the return to Premier League action.
go into the match off the back of a fine 4-1 win over Aston Villa in the Premier League. However, they followed that up with a 3-2 defeat to Galatasaray in the Europa League on Thursday - their first defeat in that competition.
know that they could leap as high as third in the Premier League table with a win over the Tractor Boys, if results elsewhere go their way - and that would be a huge tonic as we head into the third and final international break of 2024.
READ MORE:
READ MORE:
is sure to be questioned on the state of his squad heading into the match at Tottenham Hotspur Stadium though. There are question marks over a number of high-profile players, with Spurs forced into big changes in the defeat to Galatasaray.
will be missing for the Ipswich match, having picked up a hamstring injury against Manchester City in the Carabao Cup. and Wilson Odobert are also ruled out with hamstring and thigh injuries respectively.
However, there are other concerns. Cristian Romero was not risked for the Galatasaray clash, staying at home with a foot injury. Timo Werner was another to remain at home with a groin complaint.
Djed Spence has been missing for a number of weeks, while teenager Mikey Moore also missed the trip to Turkey with a virus.
Tottenham are walking wounded, particularly in defensive positions, and Postecoglou will be hoping to hve better news to share with the assembled media ahead of the game with Ipswich.
You may also like
CJI DY Chandrachud's emotional farewell speech: 'No greater feeling than being able to serve those in need'
Anil Ambani: Anil Ambani got a shock just 24 hours after getting the good news, Reliance Power was banned for 3 years
WAAYU Takes Its Services To Hyderabad, Secunderabad
'You always want more': Howe on completing three-year as Newcastle head coach
Lupus cure could be on the horizon as 'groundbreaking' autoimmune drug starts trials